Technology
Funding from the venture capital firm's Customer Value Fund will allow Commure to accelerate its expansion in healthcare without ownership dilution.
The funding comes on the heels of the fax automation company's $37 million Series B funding round and $18 million Series A raise last year.
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.
Anne Osdoit, CEO of Moon Surgical, discusses the company’s Maestro surgical robotics system and how it supports surgeons during soft tissue procedures.
Anne Osdoit, CEO of Moon Surgical, says the company’s robotic surgery offering serves as a surgical assistant in laparoscopic soft tissue procedures, using robotic arms to hold instruments and AI to give insights into workflow efficiency.
The partnership will allow Oura Ring wearers to share their biometric data with the virtual women's health company's care teams.
HIMSS25
From documenting bedside prayers to helping a hard-of-hearing nurse connect with patients, AI tools are revealing the importance of nurses' and patients' emotional and spiritual bonds to healing, says Mercy's Tracy Breece.
Lyrebird Health plans to scale its operation internationally, beginning in the United Kingdom.
The company's valuation has increased by $1 billion since its $130 million Series E funding round last year.
HIMSS25
According to Tony DiGiorgio, chief architect at Symplr, the company has carefully embedded AI into its operational platform to cut administrative redundancy and enable nurses to minimize the number of systems they use each day.